Friday 30th October 2020 Missed our free GatewayC webinar on Lung Cancer vs COVID-19? Watch our recording here. In this webinar GatewayC met Dr Matthew Evison, Consultant Chest Physician and Director of the Lung Pathway Board, and Dr Seamus Grundy, Consultant...
Cancer Keys: The two tests that will diagnose at least 90% of myeloma patients
Latest from the Blog
Meet the specialists: acute leukaemia Q&A
Friday 23rd October 2020 Missed our free GatewayC webinar on Acute Leukaemia? Watch our recording here. In this webinar GatewayC met Dr Amit Patel, a Consultant in Cellular Therapies and Stem Cell Transplantation, who answered key questions from our audience. These...
Related Posts
Cancer Keys: RUQ Pain in Pancreatic Cancer
Pancreatic cancer diagnoses can be missed due to the non-site specific nature of some early symptoms. However, according to CRUK, up to 70% of patients with pancreatic cancer initially visit the doctor with upper abdominal or back pain. Potential Pitfall Pain often...
Cancer Keys: PPIs masking red flag symptoms for stomach cancer
Proton Pump Inhibitors (PPIs) are widely used to treat acid reflux and dyspepsia. NICE cautions that PPIs can mask or alter symptoms of stomach cancer, leading to later diagnoses. Potential Pitfall Patients on PPIs who have developed stomach cancer may increase their...

Myeloma investigations
If you are suspicious of myeloma following blood results, there are two pertinent investigations that can be ordered in primary care to give a strong case for referral:
1. Serum protein electrophoresis test
2. Bence-Jones protein urine test
Potential Pitfall
If you test for serum protein electrophoresis alone, you will identify only 2/3 of patients.
Helpful hint
Most patients with untreated myeloma have a monoclonal immunoglobulin peak in serum, urine, or both. A combination of serum protein electrophoresis and Bence-Jones protein urine test will diagnose up to 95% of patients with myeloma without any form of imaging. NICE NG12 guidelines suggest making a suspected cancer referral for patients whose investigation results indicate myeloma.
Cancer Keys are brought to you by GatewayC.
Download this Cancer Key here.
Access GatewayC’s Myeloma – Early Diagnosis course.

Latest from the Blog
Meet the specialists: lung cancer vs COVID-19 Q&A
Friday 30th October 2020 Missed our free GatewayC webinar on Lung Cancer vs COVID-19? Watch our recording here. In this webinar GatewayC met Dr Matthew Evison, Consultant Chest Physician and Director of the Lung Pathway Board, and Dr Seamus Grundy, Consultant...
Meet the specialists: acute leukaemia Q&A
Friday 23rd October 2020 Missed our free GatewayC webinar on Acute Leukaemia? Watch our recording here. In this webinar GatewayC met Dr Amit Patel, a Consultant in Cellular Therapies and Stem Cell Transplantation, who answered key questions from our audience. These...
Related Posts
Cancer Keys: RUQ Pain in Pancreatic Cancer
Pancreatic cancer diagnoses can be missed due to the non-site specific nature of some early symptoms. However, according to CRUK, up to 70% of patients with pancreatic cancer initially visit the doctor with upper abdominal or back pain. Potential Pitfall Pain often...
Cancer Keys: PPIs masking red flag symptoms for stomach cancer
Proton Pump Inhibitors (PPIs) are widely used to treat acid reflux and dyspepsia. NICE cautions that PPIs can mask or alter symptoms of stomach cancer, leading to later diagnoses. Potential Pitfall Patients on PPIs who have developed stomach cancer may increase their...